成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 241479-67-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 241479-67-4
Chemical Structure| 241479-67-4
Structure of 241479-67-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 241479-67-4 ]

Related Doc. of [ 241479-67-4 ]

Alternatived Products of [ 241479-67-4 ]
Product Citations

Product Details of [ 241479-67-4 ]

CAS No. :241479-67-4 MDL No. :
Formula : C22H17F2N5OS Boiling Point : -
Linear Structure Formula :- InChI Key :DDFOUSQFMYRUQK-RCDICMHDSA-N
M.W : 437.47 Pubchem ID :6918485
Synonyms :
BAL-4815;RO-0094815;trade name Cresemba.;BAL-8557-002
Chemical Name :4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile

Calculated chemistry of [ 241479-67-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 22
Fraction Csp3 : 0.18
Num. rotatable bonds : 6
Num. H-bond acceptors : 7.0
Num. H-bond donors : 1.0
Molar Refractivity : 111.46
TPSA : 115.86 ?2

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.26
Log Po/w (XLOGP3) : 3.54
Log Po/w (WLOGP) : 4.97
Log Po/w (MLOGP) : 2.46
Log Po/w (SILICOS-IT) : 5.2
Consensus Log Po/w : 3.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.91
Solubility : 0.00536 mg/ml ; 0.0000123 mol/l
Class : Moderately soluble
Log S (Ali) : -5.66
Solubility : 0.000962 mg/ml ; 0.0000022 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.33
Solubility : 0.0000204 mg/ml ; 0.0000000466 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.26

Safety of [ 241479-67-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 241479-67-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 241479-67-4 ]

[ 241479-67-4 ] Synthesis Path-Downstream   1~14

  • 1
  • [ 186353-05-9 ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-phenyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
  • 2
  • acetic acid 2-(iodomethoxycarbonyl-methyl-amino)-ethyl ester [ No CAS ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-2-(acetoxy)ethyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 3
  • [N-methyl-N-3-(acetoxy)propyl]carbamic acid chloromethyl ester [ No CAS ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-3-(acetoxy)propyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 4
  • [ 338990-23-1 ]
  • [ 241479-67-4 ]
  • [[2(S)-(acetoxymethyl)pyrrolidin-1-yl]carbonyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 5
  • [ 338990-20-8 ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-2-(acetoxymethyl)phenyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
63% sodium iodide; In acetonitrile; at 20 - 80℃; for 9h; A solution of 1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl-1H-[1,2,4]triazol (200 mg, 0.457 mmol), sodium iodide (6.8 mg 0.045 mmol) and acetic acid 2-(chloromethoxycarbonyl-methyl-amino)-benzyl ester 150 mg, 0.552 mmol) was stirred for 6 h at ambient temperature and then at 80° C. for 3 h under Ar atmosphere. The reaction mixture was concentrated under reduced pressure and the resulting material was eluted on a column of silica gel (Kusano Si-5, eluent dichloromethane:methanol=20:1). The fractions containing the product were concentrated under reduced pressure giving the title compound a) as colorless amorphous (204.5 mg, 63percent). 1H-NMR (270 MHz, DMSO-d6): delta 1.20 (3H, d, J=6.9), 1.99 (3H, s), 3.12 (2.4H, s), 3.15 (0.6H, s), 4.15 (1H, q, J=7.3), 4.79-4.91 (3H, m), 5.09 (1H, d, J=14.8), 5.76 (1H, s), 5.90-6.10 (1.6H, m), 6.17 (0.4H, br.s), 6.61-6.66 (1H, m), 7.05-7.15 (1H, m), 7.26-7.44 (6H, m), 7.91-7.96 (2H, m), 8.20-8.24 (2H, m),8.49 (1H, s), 9.01 (0.8H, br.d, J=3.6), 9.12 (0.2H, br.s), 10.16 (0.8H, br.d, J=4.9), 10.27 (0.2H, br.s); FAB-MS: 673 (M-Cl)+; Ratio of Retention Time in HPLC: 1.79 (see Example D).
  • 6
  • [ 338990-31-1 ]
  • [ 241479-67-4 ]
  • 1-[[N-methyl-N-3-[(t-butoxycarbonylmethylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
  • 7
  • [ 338990-41-3 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-5-chloro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 8
  • [ 338990-44-6 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-3-fluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 9
  • [ 338990-35-5 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-4-fluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 10
  • [ 338990-34-4 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-4,5-difluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 11
  • [ 338990-27-5 ]
  • [ 241479-67-4 ]
  • [ 338990-62-8 ]
YieldReaction ConditionsOperation in experiment
51% sodium iodide; In acetonitrile; at 70℃; To a solution of [N-methyl-N-2-((tert-butoxycarbonylisopropylamino)methyl)phenyl]carbamic acid 1-chloro-ethyl ester (143 mg, 0.342 mmol) in acetonitrile (1 ml) was added the azole compound (163 mg, 0.372 mmol) and catalytic amount of sodium iodide at 70° C. After stirring overnight, the solvent was removed and extracted with ethyl acetate. The organic phase was washed with water and brine. The solvent was removed in vacuo. The residue was purified by column chromatography (ethyl acetate to 10percent methanel-dichloromethane) to afford 1-[[N-methyl-N-2-(t-butoxycarbonyl-isopropylaminomethyl)phenyl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyano-phenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride (155 mg, 0.189 mmol, 51percent) as off-white amorphous.
  • 12
  • [ 338990-31-1 ]
  • [ 241479-67-4 ]
  • 1-[[N-methyl-N-3-[(t-butoxycarbonylmethylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]-triazo-4-ium iodide [ No CAS ]
YieldReaction ConditionsOperation in experiment
88.4% With sodium iodide; In acetonitrile; at 45 - 50℃; for 15h; [N-methyl-N-3-((tert-butoxycarbonylmethylamino)acetoxymethyl)pyridin-2-yl]carbamic acid 1-chloro-ethyl ester(q) (55 g, 0.132 mol, 1.4 eq) and the azole compound of Example 5a) (41.2 g, 0.0944 mol) was dissolved in CH3CN(350 mL) and warmed to 45-50 C. To the solution was added NaI(19.7 g, 0.131 mol, 1.4 eq) and stirred for 15 h. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure. The obtained residue was purified by silicagel columnchromatography((eluent: fromAcOEt to AcOEt/MeOH (10/1,v/v) gradient) to give the product as its iodide form(78.7 g, 88.4% yield). [00418] The iodide (66.5 g, 0.07 mol) was dissolved in MeOH(300 mL) and distilled water(200 mL) at 0 C. and strong anion exchange resin[Dia Ion SA10A(200 g)]was added to the solution. The mixture was stirred using an evaporator. After 1 h, the mixture was filtered, washed with methanol and the filtrate was evaporated. The obtained residue was diluted with water(200 mL), brine(200 mL) and ethyl acetate(500 mL). The organic layer was extracted with ethyl acetate and combined ethyl acetate layer was dried over Na2SO4 and concentrated under reduced pressure. The obtained residue was purified by silicagel column chromatography((eluent:DCM/MeOH(10/1, v/v)) to give the product (52.1 g, 86.7% yield).
83% With sodium iodide; In acetonitrile; at 50 - 60℃; for 12h;Inert atmosphere; Adding a compound of formula 1 (50 g) to a 500 ml single-mouth round bottom reaction flask,Compound of formula 2 (67 g), NaI (24 g) and anhydrous MeCN (250 ml),Nitrogen replacement, nitrogen protection; heating to 60 C oil temperature, internal temperature 50 C,Stirring for 12 hours; cooling to below 20 C, filtering, filter cake washed with EA;EA (200 ml) and purified water (500 ml) were added to the filtrate, and the mixture was stirred and extracted;Separate, the upper EA phase is wine red; the lower aqueous phase is extracted twice with EA (50 ml).The organic phases were combined and washed with aq. NaCI (50 mL).Dryed by adding 20 g of anhydrous sodium sulfate and concentrated under reduced pressure to give a foamy solid.Used directly in the next reaction;The yield was 83% and the HPLC purity was >90%.
With potassium iodide; In acetonitrile; at 47 - 50℃; <strong>[241479-67-4]Isavuconazole</strong> (20 g) and [N-methyl-N-3((tert-butoxycarbonylmethylamino)acetoxy methyl)pyridine-2-yl]carbamic acid 1 -chloro-ethyl ester (24.7 g) were dissolved in acetonitrile (200ml). The reaction mixture was stirred to add potassium iodide (9.9 g). The reaction mixture was stirred at 47-50C for 10-13 hour. The reaction mixture was cooled to room temperature. The reaction mass was filtered through celite bed and washed acetonitrile. Residue was concentrated under reduced pressure to give the crude solid product (47.7 g). The crude product was purified by column chromatography to get its pure iodide form (36.5 g). Yield: 84.5 % HPLC Purity: 87% Mass: m/z 817.4 (M-I)+
  • 13
  • [ 338990-56-0 ]
  • [ 241479-67-4 ]
  • 1-[[N-ethyl-N-2-(t-butoxycarbonylethylamino)ethyl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
86% sodium iodide; In acetonitrile; at 60℃; [00474] To a solution of [N-ethyl-N-(tert-butoxycarbonyl ethylamino)ethyl]carbamic acid 1-chloro-ethyl ester (t) (500 mg, 1.55 mmol) in acetonitrile (1 ml) was added the azole compound of Example 5a) (438 mg, 1 mmol) and catalytic amount of sodium iodide at 60° C. After stirring overnight, the solvent was removed and extracted with ethyl acetate. The organic phase was washed with water and brine. The solvent was removed in vacuo. The residue was purified by column chromatography (ethyl acetate to 10percent methanel-dichloromethane) to afford 1-[[N-ethyl-N-2-(t-butoxy carbonylehylamino)ethyl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride (alpha) (654 mg, 0.860 mmol, 86percent) as light brown amorphous.
  • 14
  • (2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide [ No CAS ]
  • [ 20099-89-2 ]
  • [ 241479-67-4 ]
YieldReaction ConditionsOperation in experiment
86% With sodium hydrogencarbonate; In ethanol; h) Preparation of 4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl}-benzonitrile A mixture of (2R,3R)-3-(2,5-Difluoro-phenyl)-3-hydroxy-2-methyl-4-[1,2,4]triazol-1-ylthiobutyramide (26.7 g, 85.4 mmol) and a-bromo-4'-cyano-acetophenone (24.0 g, 0.107 mol) in EtOH (500 ml) was refluxed for 1 hr. The reaction mixture was cooled down to r.t. And the solvent was removed under reduced pressure down to 150 ml. The residue was poured into in to cold (0° C.) saturated NaHCO3 aq. (400 ml). The resulting mixture was extracted with EtOAc (300 ml+150 ml*2). The combined organic layer was washed with brine (200 ml), dried over Na2SO4 and concentrated in vacuo. The residue was chromatographed on silica gel (Wako-gel C-300, Hexane:EtOAc=1:2) to give 4-{2-[(1R,2R)-2-(2,5-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-thiazol-4-yl }-benzonitrile (32.0 g, 86percent). Physical form: colorless heavy syrup; ESI-MS: m/z 437 (M)+; 1H-NMR(CDCl3): 1.25(3H,d,J=7.3 Hz),4.12(1 H,q,J=7.3 Hz),4.26,4.96 (2H,Abq,J=14.5 Hz), 5.75(1H,s),6.89~7.07(2H,m),7.23~7.29(1 H,m),7.65 (1H,s),7.71(1H,s),7.75, 8.02(4H,Abq,J=8.6 Hz),7.85(1H,s).
77.4% In ethanol; at 78℃; for 3h; The white solid obtained above (3.85 g, 12.75 mmol) was dissolved in absolute ethanol (60 ml), then add alpha-bromo-4-cyanoacetophenone (3.14g, 14.02mmol) to 78°C,The reaction was refluxed for 3 h. After cooling to room temperature, the reaction solution was concentrated and extracted with ethyl acetate.The ethyl acetate phase is washed with saturated sodium bicarbonate solution, the organic phase is dried and concentrated.Ice methyl tert-butyl ether washing, drying white solidIsoconazole4.31g(yield: 77.4percent, e.e. >99percent, d.e. >99percent).
In ethanol; at 70℃; In a round bottomed flask charged ethanol (250 ml), thioamide compound (25.0 gm) and 4-cyano phenacyl bromide (18.4 gm) under stirring. The reaction mixture were heated to 70 °C. After completion of reaction the solvent was removed under vacnum distillation and water (250 ml) and Ethyl acetate (350 ml) were added to reaction mass. The reaction mixture was stirred and its pH was adjusted between 7 to 7.5 by 10 percent solution of sodium bicarbonate. The layer aqneous layer was discarded and organic layer was washed with saturated sodium chloride solution (100 ml) and concentrated under vacuum to get residue. The residue was suspended in methyl tert-butyl ether (250 ml) and the reaction mixtnre was heated to at 40°C to make crystals uniform and finally reaction mass is cooled to room temperature filtered and washed with the methyl tert-butyl ether. The product was isolated dried to get pale yellowish solid product.Yield: 26.5 gmHPLC purity: 92.7percent
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;